Pontifax

Pontifax Pontifax is one of Israel's leading life sciences venture firms, managing $800M+ across 6 funds since 2004. The team includes MDs, PhDs, and former pharmaceutical executives, providing the clinical and scientific depth needed to evaluate early-stage therapeutic programs. Notable exits include Kymera Therapeutics (IPO), BiomX (IPO), and Augmedics, with 30+ portfolio exits including 10+ IPOs and major M&A transactions. The investment focus covers therapeutics, drug discovery, medical devi